CLS’ management team has extensive experience in product and business development of medtech products, as well as in cancer care, regulatory work and international marketing.
CEO since 2022
CLS employee since 2014, acting CEO 2020-2022
Dan Mogren has 20 years of experience from leading positions in business and product development, marketing and sales, as well as 15 years of experience in international marketing of medical devices. Dan Mogren has founded and developed several companies in the medical device field.
Holdings in CLS: 43,451 class B shares plus 632 class B shares via Medinovus AB.
COO since 2023
Jimmy Johansson, MSc Electrical Engineering, has extensive experience from medical device and healthcare sector. Jimmy Johansson has previously held several leading positions in business and product development, as well as quality assurance of medical devices, at various companies.
Holdings in CLS: 429 class B shares plus 130, 000 class B shares via Medtech Öresund AB.
Interim CFO
Håkan Rosqvist has 15 years of experience from leading positions at Sony Mobile Communications. Since 2016, Håkan has also held several executive roles within finance, financial controlling, and business development, and which also included capital raising, at various growth companies, including Tretton37, Spiideo and Evidensia.
CPO since 2020
Verena Knappe, Graduate Engineer in Biomedical Engineering with extensive experience in scientific research and product development for laser interstitial thermal therapy (LITT). Verena’s background from previous manager positions is laser medicine, quality assurance of active medical devices and business development. Verena is also the inventor of the diffusor technology used in the non-cooled Laser applicator.
CTO since 2022
Cristina Pantaleone, MSc Physics Engineering, has experience in the development of medical devices, expertise in light-tissue interaction and a deep understanding of CLS’s technology and product range.
Holdings in CLS: 1,344 class B shares.
VP Regulatory Affairs &
Quality Assurance since 2021
Anders Qvarlander has extensive experience from leading positions within market expansion, regulatory product approvals and quality assurance of medical devices from previous employments at Baxter, Arjo and Mediplast, among others.
Holdings in CLS: 700 class B shares.
VP Medical Affairs since 2023
Kristian Waldeck, PhD in Experimental Clinical Pharmacology and MSc in Electrical Engineering. Kristian has worked for over 25 years in senior positions in life science and medical devices within marketing and medical affairs. Kristian’s previous work experience includes Arjo, Hemocue, Mitra Medical, ProstaLund, Siemens and his own consulting company.
Holdings in CLS: 20,000 class B shares via Walmed AB.
Last updated on 2025-07-11
Welcome to Clinical Laserthermia Systems.
Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!
Please choose your country or region
